These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 36623329)

  • 21. A facile reaction to access novel structural sulfonyl-hybridized imidazolyl ethanols as potential DNA-targeting antibacterial agents.
    Bheemanaboina RRY; Wang J; Hu YY; Meng JP; Guan Z; Zhou CH
    Bioorg Med Chem Lett; 2021 Sep; 47():128198. PubMed ID: 34119615
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Potent antibacterial activity of oligo-3-aminopyridine against Staphylococcus aureus and Enterococcus faecalis.
    Akgul C; Kaya I
    Indian J Biochem Biophys; 2004; 41(2-3):120-2. PubMed ID: 22900341
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Topoisomerase mutations and efflux are associated with fluoroquinolone resistance in Enterococcus faecalis.
    Oyamada Y; Ito H; Inoue M; Yamagishi JI
    J Med Microbiol; 2006 Oct; 55(Pt 10):1395-1401. PubMed ID: 17005789
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A New Discovery of Unique 13-(Benzimidazolylmethyl)berberines as Promising Broad-Spectrum Antibacterial Agents.
    Sun H; Li ZZ; Jeyakkumar P; Zang ZL; Fang B; Zhou CH
    J Agric Food Chem; 2022 Oct; 70(39):12320-12329. PubMed ID: 36135960
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro and in vivo antibacterial activities of KB-5246, a new tetracyclic quinolone.
    Kotera Y; Mitsuhashi S
    Antimicrob Agents Chemother; 1989 Nov; 33(11):1896-900. PubMed ID: 2610501
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of solithromycin with erythromycin in Enterococcus faecalis and Enterococcus faecium from China: antibacterial activity, clonality, resistance mechanism, and inhibition of biofilm formation.
    Wang Y; Xiong Y; Wang Z; Zheng J; Xu G; Deng Q; Wen Z; Yu Z
    J Antibiot (Tokyo); 2021 Feb; 74(2):143-151. PubMed ID: 33077828
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Matrix Metalloproteinase Inhibitor as an Antimicrobial Agent to Eradicate Enterococcus faecalis Biofilm.
    Tay CX; Quah SY; Lui JN; Yu VS; Tan KS
    J Endod; 2015 Jun; 41(6):858-63. PubMed ID: 25814242
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro antibacterial activity of the peptide PsVP-10 against antimicrobial-resistant Enterococcus faecalis isolated from clinical samples.
    Padilla C; Lobos O; Brevis P; Abaca P; Hubert E
    J Antimicrob Chemother; 2004 Feb; 53(2):390-2. PubMed ID: 14729763
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel naphthalimide nitroimidazoles as multitargeting antibacterial agents against resistant Acinetobacter baumannii.
    Kang J; Gopala L; Reddy Tangadanchu VK; Gao WW; Zhou CH
    Future Med Chem; 2018 Apr; 10(7):711-724. PubMed ID: 29671618
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessment of the Antibacterial Effects of Bismuth Nanoparticles against
    Azad A; Rostamifar S; Modaresi F; Bazrafkan A; Rezaie Z
    Biomed Res Int; 2020; 2020():5465439. PubMed ID: 33150176
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel metronidazole-derived three-component hybrids as promising broad-spectrum agents to combat oppressive bacterial resistance.
    Li FF; Zhang PL; Tangadanchu VKR; Li S; Zhou CH
    Bioorg Chem; 2022 May; 122():105718. PubMed ID: 35255343
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Discovery of 2-aminothiazolyl berberine derivatives as effectively antibacterial agents toward clinically drug-resistant Gram-negative Acinetobacter baumanii.
    Gao WW; Gopala L; Bheemanaboina RRY; Zhang GB; Li S; Zhou CH
    Eur J Med Chem; 2018 Feb; 146():15-37. PubMed ID: 29396362
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis of chitosan-alginate microspheres with high antimicrobial and antibiofilm activity against multi-drug resistant microbial pathogens.
    Thaya R; Vaseeharan B; Sivakamavalli J; Iswarya A; Govindarajan M; Alharbi NS; Kadaikunnan S; Al-Anbr MN; Khaled JM; Benelli G
    Microb Pathog; 2018 Jan; 114():17-24. PubMed ID: 29138082
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel amylomacins from seaweed-associated Bacillus amyloliquefaciens as prospective antimicrobial leads attenuating resistant bacteria.
    Chakraborty K; Kizhakkekalam VK; Joy M; Chakraborty RD
    World J Microbiol Biotechnol; 2021 Oct; 37(12):200. PubMed ID: 34664128
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of MTADN on 10 Enterococcus faecalis isolates and biofilm: an in vitro study.
    Tong Z; Ling J; Lin Z; Li X; Mu Y
    J Endod; 2013 May; 39(5):674-8. PubMed ID: 23611389
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sulfonamide-Derived Four-Component Molecular Hybrids as Novel DNA-Targeting Membrane Active Potentiators against Clinical Escherichia coli.
    Hu YY; Yadav Bheemanaboina RR; Battini N; Zhou CH
    Mol Pharm; 2019 Mar; 16(3):1036-1052. PubMed ID: 30638386
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antibacterial and Antibiofilm Activity of Juglone Derivatives against
    Niaz F; Faheem M; Khattak M; Khawaja IA; Ahn MJ; Sarker U; Jamal SB; Ullah R; Khalil AAK
    Biomed Res Int; 2022; 2022():6197375. PubMed ID: 36408282
    [No Abstract]   [Full Text] [Related]  

  • 38. Discovery of quinolinequinones with N-phenylpiperazine by conversion of hydroxyquinoline as a new class of antimicrobial agents targeting resistant pathogenic microorganisms.
    Yıldız M; Bayrak N; Yıldırım H; Çakmak SM; Yılmaz FN; Mataracı-Kara E; Shilkar D; Jayaprakash V; TuYuN AF
    Bioorg Chem; 2022 Nov; 128():106045. PubMed ID: 35921788
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Norfloxacin salts of carboxylic acids curtail planktonic and biofilm mode of growth in ESKAPE pathogens.
    Lowrence RC; Ramakrishnan A; Sundaramoorthy NS; Shyam A; Mohan V; Subbarao HMV; Ulaganathan V; Raman T; Solomon A; Nagarajan S
    J Appl Microbiol; 2018 Feb; 124(2):408-422. PubMed ID: 29178633
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antimicrobial Activity of Phytic Acid: An Emerging Agent in Endodontics.
    Nassar R; Nassar M; Vianna ME; Naidoo N; Alqutami F; Kaklamanos EG; Senok A; Williams D
    Front Cell Infect Microbiol; 2021; 11():753649. PubMed ID: 34765567
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.